# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-002375
Filing Date
2024-01-26
Accepted
2024-01-26 17:25:20
Documents
23
Period of Report
2024-01-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | arwr-20240126.htm iXBRL | DEF 14A | 979121
6 |  | arwr-20240126_g1.jpg | GRAPHIC | 206998
7 |  | arwr-20240126_g10.jpg | GRAPHIC | 427199
8 |  | arwr-20240126_g2.jpg | GRAPHIC | 68095
9 |  | arwr-20240126_g3.jpg | GRAPHIC | 54665
10 |  | arwr-20240126_g4.jpg | GRAPHIC | 50524
11 |  | arwr-20240126_g5.jpg | GRAPHIC | 20090
12 |  | arwr-20240126_g6.jpg | GRAPHIC | 96930
13 |  | arwr-20240126_g7.jpg | GRAPHIC | 134549
14 |  | arwr-20240126_g8.jpg | GRAPHIC | 111675
15 |  | arwr-20240126_g9.jpg | GRAPHIC | 490601
| Complete submission text file | 0001628280-24-002375.txt |  | 5443414

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | arwr-20240126.xsd | EX-101.SCH | 3305
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | arwr-20240126_def.xml | EX-101.DEF | 4212
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | arwr-20240126_lab.xml | EX-101.LAB | 5706
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | arwr-20240126_pre.xml | EX-101.PRE | 3217
18 | EXTRACTED XBRL INSTANCE DOCUMENT | arwr-20240126_htm.xml | XML | 113783

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38042 | Film No.: 24569136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)